http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015182524-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bf7b82e0f0ef387acf43f2ddd705ccf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
filingDate 2015-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7263ad93696b0abdaf842127dc1d7f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f89d92b3a47e5d85424f44ffa32198eb
publicationDate 2015-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015182524-A1
titleOfInvention Compositions and methods for weight loss in at risk patient populations
abstract The present disclosure relates to compositions, kits, uses, systems and methods related to naltrexone plus bupropion for treating an overweight or obese subject at increased risk of adverse cardiovascular outcomes. Preferably, the subject has had type-two diabetes for a period of less than 6 years or is a current smoker, optionally that does not have type-two diabetes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10238647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457005-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11033543-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10322121-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9801875-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10231962-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9633575-B2
priorityDate 2013-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129262404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444

Total number of triples: 52.